Company
CSL Limited
ASX:CSL
CSL Limited is an Australian-based company biopharmaceutical company that researches, develops, manufactures and markets biotherapies to treat and prevent human medical conditions.
20 stories
Threat of war drives markets down and oil up
“I think a war will mean wobbly equity markets, but I think the impact on bond yields is contestable because a war would exacerbate current supply chain bottlenecks, it would probably mean a rapid increase in energy prices, and it might esc
CSL reaches record demand for seasonal influenza vaccines
The company's flu business, Seqirus, delivered revenue growth of around 38% on the back of a 44% increase in flu vaccinations, says S&P Global.
Investments and investor services
S&P/ASX 200 down 1.31% early afternoon on second worst day of 2019
Concerns of a global slowdown drag the big four banks, major miners and energy sector lower.
Hardware & electrical equipment
ShareRoot increases the Social Science takings amid MediaConsent interest
The consumer data security provider is aiming to grow revenue and reduce spending in the coming year.
Paradigm Biopharmaceuticals banking on near-term revenues from repurposing FDA approved drugs
Paradigm’s share price has increased more than 60% in the last month and it was up more than 12% on Friday.